CONSUN PHARMAC.GR.HD -10 (C1P) — Defensive Interval Ratio
CONSUN PHARMAC.GR.HD -10 (C1P) has a Defensive Interval Ratio of 745 days as of December 2025. Defensive assets of €2.92 Billion (cash €-, short-term investments €2.67 Billion, receivables €251.32 Million) cover 745 days of daily cash needs of €3.92 Million/day. See CONSUN PHARMAC.GR.HD -10 working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
CONSUN PHARMAC.GR.HD -10 Defensive Interval Ratio (2021–2025)
This chart shows how CONSUN PHARMAC.GR.HD -10's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 745 days, meaning defensive assets of €2.92 Billion can fund 745 days of operations without new revenue. See CONSUN PHARMAC.GR.HD -10 net asset quality index to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for CONSUN PHARMAC.GR.HD -10 (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for CONSUN PHARMAC.GR.HD -10 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see C1P market cap.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 745 days | €2.92 Billion | €3.92 Million/day | €- | €2.67 Billion | ▲ +428 days |
| 2024 | 317 days | €1.19 Billion | €3.76 Million/day | €- | €958.00 Million | ▲ +66 days |
| 2023 | 251 days | €1.03 Billion | €4.10 Million/day | €- | €834.94 Million | ▲ +48 days |
| 2022 | 203 days | €752.41 Million | €3.70 Million/day | €- | €589.17 Million | ▲ +82 days |
| 2021 | 122 days | €452.59 Million | €3.72 Million/day | €- | €230.00 Million | — |